SCHEMBL23093840

SCHEMBL23093840

CNCCCOc1ccc(-c2ccc3ncc4c(C)nc(N5C[C@@H](C)O[C@@H](C)C5)n4c3c2)cn1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 19/20 0.48
▸ MTOR P42345 13/20 0.48
▸ PIK3CA P42336 11/20 0.48
▸ ATR Q13535 7/20 0.48
▸ PRKDC P78527 3/20 0.41
▸ PAICS P22234 1/20 0.37
▸ PIK3CB P42338 2/20 0.37
▸ ATRIP Q8WXE1 1/20 0.37
▸ PIK3CD O00329 1/20 0.36
▸ PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29688027 1.00 ATM (0.48) ATMMTORPIK3CAATRPRKDC
SCHEMBL23093862 0.92 ATM (0.41) ATMMTORPIK3CAATRPRKDC
SCHEMBL29688047 0.92 ATM (0.41) ATMMTORPIK3CAATRPRKDC
SCHEMBL29688283 0.91 ATM (0.42) ATMMTORPIK3CAATRPRKDC
SCHEMBL23093827 0.91 ATM (0.42) ATMMTORPIK3CAATRPRKDC
SCHEMBL23119299 0.89 ATM (0.54) ATMMTORPIK3CAATRPRKDC
SCHEMBL23093830 0.89 ATM (0.54) ATMMTORPIK3CAATRPRKDC
SCHEMBL23119298 0.89 ATM (0.54) ATMMTORPIK3CAATRPRKDC
SCHEMBL23119186 0.88 ATM (0.49) ATMMTORPIK3CAATRPRKDC
SCHEMBL23093919 0.88 ATM (0.49) ATMMTORPIK3CAATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4028400-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2022-07-20 — — EP claimed
WO-2021047646-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF IMPACT THERAPEUTICS, INC (CN) 2021-03-18 — — WO claimed
EP-4028400-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2022-07-20 — — EP disclosed
WO-2021047646-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF IMPACT THERAPEUTICS, INC (CN) 2021-03-18 — — WO disclosed
Send feedback